SHANGHAI, 2 juillet 2024 /PRNewswire/ — Pulnovo Medical Limited, société pionnière et mondialement reconnue dans le traitement de l’hypertension pulmonaire (HTP) et de l’insuffisance cardiaque (IC), a le plaisir d’annoncer le lancement réussi et le recrutement des deux premiers patients…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.